Product Highlight - Dapagliflozin (Glifixy)

20 Feb 2025
Product Highlight - Dapagliflozin (Glifixy)

Your Glycemic fix for a diverse mix

  • Dapagliflozin is indicated in adults
  • For the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:
     - as monotherapy when metformin is considered inappropriate due to intolerance.
     - in addition to other medicinal products for the treatment of type 2 diabetes.1
  • For the treatment of symptomatic chronic heart failure with reduced ejection fraction.1
  • For the treatment of chronic kidney disease.1

 

Reference:
1. Product Information of Glifixy – June 23, 2024


SANDOZ PHILIPPINES CORPORATION
Unit 601, 6th Flr of Ayala North Exchange Tower 1 (HQ),
Ayala Ave cor Salcedo & Amorsolo Sts, Makati City
Phone: (+63-2) 7368 7098

Related MIMS Drugs